Everolimus Tablet
Product Images NDC 70377-070

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 70377-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label-0.25-mg.jpg (0.25mg Bottle)

The packaging label for Everolimus Tablets 0.25 mg features the Biocon logo and states a quantity of 60 tablets. It includes storage instructions to keep at 20°C to 25°C, cautions to protect from light and moisture, and a child-resistant package notice. The product is manufactured for Biocon Pharma Inc., Iselin, NJ, USA, and by Biocon Pharma Limited, Bengaluru, India. The label also has an NDC code 70377-069-11 and a barcode.*

FDA Label Image

Bottle-label-0.5-mg.jpg (0.5 mg Bottle Label.jpeg)

Label for Everolimus Tablets 0.5 mg oral tablets, with 60 tablets per container. The label displays NDC 70377-070-11 and states it is for prescription use only. Manufactured by Biocon Pharma Inc., with locations in Iselin, NJ, USA, and Bengaluru, India. The label includes storage instructions, a barcode, and patient medication guide advisories.*

FDA Label Image

Bottle-label-0.75-mg.jpg (0.75 mg Bottle Label.jpeg)

Label for Everolimus Tablets 0.75 mg oral dosage form, containing 60 tablets per package. The product is manufactured for Biocon Pharma Inc. in New Jersey, USA and by Biocon Pharma Limited in Bengaluru, India. The label includes storage instructions, a barcode, and safety information advising patients to dispense the enclosed medication guide and report side effects to the FDA.*

FDA Label Image

Bottle-label-1-mg.jpg (1 mg Bottle Label.jpeg)

Label for Everolimus Tablets 1 mg oral dosage form by Biocon Pharma Inc. The package contains 60 tablets. The label includes storage instructions, dosage notice, a barcode, and manufacturer details for Biocon Pharma Inc. in New Jersey and Biocon Pharma Limited in Bengaluru, India.*

FDA Label Image

Blister-label-1-mg (1 mg Foil Label)

Blister card label for Everolimus Tablet 1 mg by Biocon Pharma Limited. The label includes NDC 70377-112-21, manufacturer information from Bengaluru, India, a barcode, and placeholders for lot number and expiration date. The medication is indicated for oral use and labeled as Rx only.*

FDA Label Image

Figure 1. Mean And 95% Ci Of Egfr (mdrd 4) [ml/min/1.73 M2] By Visit Window And Treatment After Liver Transplantation (itt Population 24 Month Analysis)* (Everolimus 05)

A line graph displaying estimated glomerular filtration rate (eGFR) over various visit windows, comparing two treatment groups: EVR+Reduced TAC and TAC Control. The x-axis shows visit windows (from Sc to M24), and the y-axis shows eGFR values in mL/min/1.73m². Data points include error bars indicating variability for each group at each visit.*

FDA Label Image

Blister-label-0.25mg-jpg (Blister 0.25mg Jpeg)

Label sheet for Everolimus Tablet 0.25 mg, oral prescription drug manufactured by Biocon Pharma Limited, Bengaluru, India. The label includes the NDC 70377-069-21, barcode, and space for lot number and expiration date. Multiple identical labels are displayed on the sheet.*

FDA Label Image

Blister-label-0.5mg-jpg (Blister 0.5mg Jpeg)

Everolimus Tablet 0.5 mg packaging label from Biocon Pharma Limited, Bengaluru, India. The label includes the product name, dosage strength, NDC code 70377-070-21, manufacturer information, barcode, and placeholders for lot and expiration date details. The label indicates the product is Rx only and is repeated in multiple identical sections on the sheet.*

FDA Label Image

Blister-label-0.75mg-jpg (Blister 0.75mg Jpeg)

This image shows a blister card label for Everolimus Tablet 0.75 mg, an oral prescription drug manufactured by Biocon Pharma Limited, Bengaluru, India. The label features the proprietary name Everolimus with dosage strength 0.75 mg, the manufacturer's information, Rx only designation, barcode, and space for lot number and expiration date information repeated in multiple sections.*

FDA Label Image

Carton-label-0.25.jpg (Carton 0.25mg Jpeg)

Packaging label for Everolimus Tablets 0.25 mg, oral tablets supplied by Biocon Pharma Inc. The label indicates a pack containing 6 blister cards with 10 tablets each, and includes storage instructions and manufacturer information for Biocon Pharma Inc., Iselin, NJ, USA and Biocon Pharma Limited, Bengaluru, India.*

FDA Label Image

Carton-label-0.5.jpg (Carton 0.5mg Jpeg)

Everolimus Tablets 0.5 mg oral tablets packaging label for Biocon Pharma Inc. The label shows the brand and generic name, strength of 0.5 mg, quantity as 6 blister cards containing 10 tablets each, storage instructions, and manufacturer information for Biocon Pharma Inc. USA and Biocon Pharma Limited, India.*

FDA Label Image

Carton-label-0.75.jpg (Carton 0.75mg Jpeg)

Packaging label for Everolimus Tablets 0.75 mg manufactured by Biocon Pharma Inc. The label shows the product name, strength (0.75 mg), blister pack contents of 6 blister cards with 10 tablets each, and storage instructions. The label includes manufacturer information for Biocon Pharma Inc. in the USA and Biocon Pharma Limited in India, along with a barcode and regulatory details.*

FDA Label Image

Carton-1-mg.jpg (Carton 1 mg.jpeg)

Everolimus Tablets 1 mg oral tablets packaging carton by Biocon Pharma Inc. The box indicates 6 blister cards of 10 tablets each. The label displays dosage strength, manufacturer information, storage instructions, and a barcode.*

FDA Label Image

Everolimus Structural Formula (1r, 9s, 12s, 15r, 16e, 18r, 19r, 21r, 23s, 24e, 26e, 28e, 30s, 32s, 35r)-1, 18-dihydroxy-12 -{(1r)-2-[(1s,3r,4r)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] Hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. (Everolimus 01)

Chemical structure of Everolimus, displaying its detailed molecular arrangement with various functional groups and chiral centers represented by directional bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.